{
    "nctId": "NCT01571921",
    "briefTitle": "Gamma-delta Tocotrienol as Potential Maintenance Treatment in Women With Metastatic Breast Cancer",
    "officialTitle": "Phase 1a: A Randomized, 2-period Cross-over Study to Compare the Bioavailability of Gamma-Delta Tocotrienol (GDT) With That of Tocotrienol Rich Fraction (TRF) in Twelve Healthy Subjects",
    "overallStatus": "COMPLETED",
    "conditions": "Healthy Subjects",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 12,
    "primaryOutcomeMeasure": "Peak Plasma Concentration (Cmax)of drug",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Male and female aged 21-55 years old\n* Good health\n* No allergy to vitamin E/ palm oil\n* No past (within 3 months) / current use of dietary supplements containing vitamin E\n\nExclusion Criteria:\n\n* History of bleeding tendencies or any condition predisposing to bleeding e.g. thrombocytopenia, abnormal liver function, liver disease (e.g. chronic hepatitis), gastrointestinal ulcers\n* Candidate for surgery or had undergone surgery in the past 6 months\n* Current or past use (last 3 months) of antithrombotic drugs such as antiplatelets (aspirin, ticlopidine), anticoagulants (heparin, warfarin), thrombolytic agents (streptokinase), etc\n* Current or past history of cancer\n* Pregnant/ breastfeeding women\n* Smokers\n* Drug or alcohol abuse\n* Hypercholesterolemia\n* Chronic conditions such as uncontrolled hypertension, heart disease (ischemic heart disease, heart failure, cardiac arrhythmia), uncontrolled diabetes, HIV infection, or other psychiatric illness/ social situations that might limit adherence to study protocol.\n* Unable or unwilling to stop taking vitamins, herbal preparations or nonprescription medications",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT"
}